PedAM
Pediatric Disease Annotations & Medicines
| Disease | acute myocardial infarction |
| Symptom | C0018801|heart failure |
| Sentences | 29 |
| PubMedID- 22357361 | heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the fast-mi registry. |
| PubMedID- 24496334 | Results: the most important predictors of early heart failure in acute myocardial infarction were age, diastolic blood pressure, creatin kinase (ck) on admission, larger field of infarction zone and so on. |
| PubMedID- 21423353 | Slowing of conduction in the presence of an arrhythmogenic substrate (acute myocardial infarction or fibrosis associated with heart failure) is a common explanation for the proarrhythmic effect of sodium channel blockers in the cast study (echt et al., 1991). |
| PubMedID- 20438292 | Material and methods: in the prospective, placebo-controlled, randomized trial, 149 consecutive acute myocardial infarction (ami) patients with heart failure undergoing primary pci received recombinant human bnp (rhbnp) or placebo from the time of admission to 24 h after pci. |
| PubMedID- 20354030 | Aims: to determine the association between obesity and outcomes in post-acute myocardial infarction (ami) patients with systolic heart failure (hf). |
| PubMedID- 26065643 | The value of abs in patients after acute myocardial infarction (ami) without heart failure is also currently determined in a recent clinical trial.2 this trial found that early ab in patients presenting for primary percutaneous coronary intervention for acute st-elevation mi is clearly associated with a reduction in the incidence of life-threatening ventricular arrhythmia. |
| PubMedID- 23408510 | Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction. |
| PubMedID- 22388688 | Heart transplantation is one of the only treatment options for heart failure due to an acute myocardial infarction, but limited donor supply and organ rejection limit its widespread use. |
| PubMedID- 23134910 | Metabolic syndrome is a risk factor for development of heart failure in acute myocardial infarction. |
| PubMedID- 24282249 | Risks associated with exercise training and testing are sudden cardiac death associated with ventricular arrhythmias, acute myocardial infarction, and in patients with chronic heart failure, pulmonary oedema and deterioration in left ventricular function.73 the last is only found in one study from 198874 and has not subsequently been demonstrated in larger studies.7576 in a recent french study of more than 25 000 patients with ischaemic heart disease, one-third with chronic heart failure found the risk of cardiac complications at 1:8500 exercise testing and 1:50 000 patient exercise hours.77 increasing exercise intensity and age are risk indicators. |
| PubMedID- 24826250 | Here we report a surgical treatment experience in an 81-year-old patient who suffered from heart failure due to acute myocardial infarction and went on to be diagnosed with valvular disease and vsd. |
| PubMedID- 24753702 | Trends in hospitalized acute myocardial infarction patients with heart failure in korea at 1998 and 2008. |
| PubMedID- 21828948 | Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. |
| PubMedID- 20124598 | Management of right heart failure in acute myocardial infarction (ami) includes emergent reperfusion of the infarct-related artery, fluid resuscitation, vasopressor and inotropic support, and trans-venous pacing in the presence of high-grade atrio-ventricular conduction block. |
| PubMedID- 21842146 | This review summarizes epidemiologic, pathophysiologic, diagnostic, and therapeutic data related to diabetes and heart failure in acute myocardial infarction and discusses novel perceptions and strategies that hold promise for the future and deserve further investigation. |
| PubMedID- 25911051 | This study aimed to evaluate the role of serum catd activity in the development of heart failure in patients with st-segment elevation acute myocardial infarction (stemi). |
| PubMedID- 25983563 | The iabp (multiple vendors, including arrow, datascope/maquet, teleflex) has a long tradition of use as an emergency aid in the treatment of acute heart failure associated with acute myocardial infarction. |
| PubMedID- 21742099 | Growth differentiation factor 15 (gdf-15) has an established role as a marker for risk stratification and mortality both in patients after acute myocardial infarction and in patients with heart failure. |
| PubMedID- 20081109 | Glp-1 improves left ventricular ejection fraction (lvef) in dogs with heart failure (hf) and in patients with acute myocardial infarction. |
| PubMedID- 23537961 | Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review. |
| PubMedID- 23363671 | Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction. |
| PubMedID- 26071031 | acute myocardial infarction patients with heart failure or diabetes grouped by their eligibility for spironolactone in 2001, 2006, and 2011. ideal: patients with a left ventricular ejection fraction (lvef) ≤40% and without contraindications to spironolactone; contraindicated: patients with a contraindication (serum potassium >5 mmol/l, or serum creatinine >2.5 mg/dl men or >2.0 mg/dl women, or documented allergy to spironolactone); not indicated: patients with neither indication (ie, lvef >40%) nor contraindication to spironolactone; unknown indications: patients whose lvef was not measured during the hospitalization. |
| PubMedID- 25014060 | Background: the classification or index of heart failure severity in patients with acute myocardial infarction (ami) was proposed by killip and kimball aiming at assessing the risk of in-hospital death and the potential benefit of specific management of care provided in coronary care units (ccu) during the decade of 60. |
| PubMedID- 24785883 | Objective: the predictors of in-hospital outcomes after primary percutaneous coronary intervention (pci) for acute myocardial infarction (ami) complicated with heart failure or cardiogenic shock at presentation remain unclear. |
| PubMedID- 24751462 | Objectives: to evaluate the efficacy of a short-term intravenous infusion of levosimendan in patients with heart failure due to acute myocardial infarction (ami). |
| PubMedID- 23046599 | Background: left ventricular (lv) remodeling takes place after acute myocardial infarction (mi), potentially leading to overt heart failure (hf). |
| PubMedID- 26110104 | The patient was diagnosed with acute decompensated heart failure due to acute myocardial infarction.figure 3axial contrast-enhanced computed tomography at the level of the heart (a), left portal vein of the liver (b), and pancreatic body (c). |
| PubMedID- 24876877 | A new born infant whose mother ingested an herbal medication, blue cohosh, to promote uterine contractions presented with acute myocardial infarction associated with profound congestive heart failure and shock 7. |
| PubMedID- 24839602 | In particular, anakinra improved left ventricular remodelling and numerically lowered the incidence of heart failure in patients with acute myocardial infarction and st-segment elevation. |
Page: 1